The two companies that produce drugs that may provide some relief from the swine flu are considered by some to present attractive investment opportunities. Both Roche, which produces Tamiflu (or oseltamivir), and GlaxoSmithKline (GSK), which produces Relenza (or zanamivir), are expected to report record earnings. But Roche recently indicated that ramping up production of Tamiflu [...]